ArticleAmerican journal of cancer research2013

BLT2 is a pro-tumorigenic mediator during cancer progression and a therapeutic target for anti-cancer drug development.

Nam-Kyu Cho et al.PubMed ↗Full text ↗

No numbers read from the abstract.